ArticleDiscover oncology2026

Aberrant expression of GBP5 in tumor-infiltrating immune cells as an onco-immunological biomarker in pan-cancer.

Rui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.